Lantern Pharma Inc.
Lantern Pharma Inc. (LTRN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LTRN · as of Jun 9, 2026
Key Statistics
Explore Lantern Pharma Inc. Data
ltrn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
Competitors & Peers
ltrn competitorsLTRN
ANVS
ATNM
BCAB
CALC
ELUTStock Performance
Full HistoryAbout Lantern Pharma Inc.
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensi…
what is lantern pharma inc. · ltrn stock overview · lantern pharma inc. company profile · who is lantern pharma inc. ceo · ltrn NASDAQ · lantern pharma inc. headquarters · lantern pharma inc. business segments
About Stock Overview & Key Data
Lantern Pharma Inc. (LTRN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 11, 2020. As of the latest trading session, LTRN stock price is $3.75, with a market capitalization of $47.8M. The stock has returned +11.28% over the past 12 months and +23.76% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Lantern Pharma Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Lantern Pharma Inc. reported revenue of — and net income of -$17.1M. For detailed data — including Lantern Pharma Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lantern Pharma Inc. (LTRN) stock price is $3.75. The stock is traded on NASDAQ under the ticker symbol LTRN. The 52-week range is $1.11 – $5.74.